These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 1280332)

  • 1. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
    Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
    Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W; Long C; Zhigang Z; Feng J; Muyi G
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
    Kagami S; Border WA; Ruoslahti E; Noble NA
    Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TGF-beta 1 in experimental glomerulonephritis.
    Border WA; Okuda S; Nakamura T; Languino LR; Ruoslahti E
    Ciba Found Symp; 1991; 157():178-89; discussion 189-93. PubMed ID: 2070683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
    Border WA; Okuda S; Languino LR; Sporn MB; Ruoslahti E
    Nature; 1990 Jul; 346(6282):371-4. PubMed ID: 2374609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
    Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells].
    Dong FQ; Li H; Wu F; Yao HP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
    Border WA; Ruoslahti E
    Cell Differ Dev; 1990 Dec; 32(3):425-31. PubMed ID: 2099240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
    Ständer M; Naumann U; Dumitrescu L; Heneka M; Löschmann P; Gulbins E; Dichgans J; Weller M
    Gene Ther; 1998 Sep; 5(9):1187-94. PubMed ID: 9930319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere.
    Logan A; Baird A; Berry M
    Exp Neurol; 1999 Oct; 159(2):504-10. PubMed ID: 10506521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
    Okuda S; Languino LR; Ruoslahti E; Border WA
    J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
    Yamamoto T; Nakamura T; Noble NA; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1814-8. PubMed ID: 7680480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
    Bruijn JA; Roos A; de Geus B; de Heer E
    J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
    Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
    Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
    Witowski J; Knapowski J
    Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
    Okuda S; Nakamura T; Yamamoto T; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9765-9. PubMed ID: 1946401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta/extracellular matrix interactions in dentin matrix: a role in regulating sequestration and protection of bioactivity.
    Baker SM; Sugars RV; Wendel M; Smith AJ; Waddington RJ; Cooper PR; Sloan AJ
    Calcif Tissue Int; 2009 Jul; 85(1):66-74. PubMed ID: 19424740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.